14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Nov 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 26, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 24, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 19, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 18, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 17, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 12, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 11, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 10, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 08, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 05, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 04, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 03, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 02, 2021 $38.00 $38.00 $38.00 $38.00 0
Nov 01, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 28, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 27, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 26, 2021 $38.00 $38.00 $38.00 $38.00 0
Oct 25, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT